Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02933255
Title PROSTVAC in Combination With Nivolumab and/or Ipilimumab in Men With Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

prostate cancer

Therapies

Ipilimumab + PROSTVAC-F-TRICOM + PROSTVAC-V-TRICOM

Ipilimumab + Nivolumab + PROSTVAC-F-TRICOM + PROSTVAC-V-TRICOM

Nivolumab + PROSTVAC-F-TRICOM + PROSTVAC-V-TRICOM

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.